Status:
COMPLETED
One More Magnetic Resonance Imaging
Lead Sponsor:
Saint Luke's Health System
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objective of this study is to utilize delayed enhanced cardiac magnetic resonance imaging to assess the success of pulmonary vein isolation after cryoablation of paroxysmal atrial fibrillation. Th...
Detailed Description
Atrial fibrillation (AF) is the most common arrhythmia in the world, affecting 1-2% of the general population and 10% of people older than 80 years old. Medical therapy is only partially effective at ...
Eligibility Criteria
Inclusion
- Age \> 18 years and \< 80 years
- A diagnosis of symptomatic paroxysmal atrial fibrillation refractory to medical therapy and planned to undergo a cryoablation procedure.
Exclusion
- Unable or unwilling to undergo magnetic resonance imaging (including implanted metal prosthesis, severe claustrophobia and inability to tolerate sedation)
- Previous atrial fibrillation ablation
- Patients who are not candidates for cryoablation procedure for treatment of atrial fibrillation
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT02293070
Start Date
December 1 2013
End Date
January 1 2017
Last Update
March 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Luke's Hospital
Kansas City, Missouri, United States, 64111